FP7Обмен на изследователи2011–2015

CHEMBIOFIGHT · Exploring Chemical Biodiversity with Innovative Approaches for Fighting Chagas and Leismaniasis

7РП — „Хора“ (Действия „Мария Кюри“)

Период
2011-04-01 → 2015-03-31
Финансиране от ЕС
434 700 €
Участници
5
Схема
MC-IRSES

Линиите свързват координатора с партньорите.

Накратко на български

Природни вещества от растения, гъби и морски организми се анализират за действие срещу болестите Шагас и лейшманиоза. Търсенето на нови активни съединения помага за разработването на по-ефективни методи за борба с тези паразитни заболявания.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Exploring Chemical Biodiversity with Innovative Approaches for Fighting Chagas and Leismaniasis

“Exploring the Chemical Biodiversity with Innovative Approaches to Fight Chagas Disease and Leishmaniasis” PIRSES-GA-2009-269301 The main goal of the ChemBioFight project is the establishment of a competent and fruitful network between European and South American educational and research entities. An innovative and well-organized scientific project aiming to the discovery of novel natural products (NPs) active against Leishmaniasis and Chagas disease comprises the basis of this attempt. State-of-the-art methodologies and advanced techniques are incorporated to this research effort, aiming towards the efficient chemical exploration of various natural sources (plants, marine organisms, fungi, endophytes) originated from highly diverse regions. Consortium (P1) NKUA (University of Athens - GREECE) - Coordinator (P2) UNIGE (University of Geneva - SWITZERLAND) (P3) UPD (University Paris Descartes - FRANCE) (P4) UL (University of Leiden - NETHERLANDS) (P5) HPI (Hellenic Pasteur Institute - GREECE) (P6) UNESP (University of Sao Paulo - BRAZIL) (P7) FIOCRUZ (Oswaldo Cruz Foundation - BRAZIL) (P8) UFSC (Federal University of Santa Catarina - BRAZIL) (P9) UNB (University of Brasilia – BRAZIL) (P10) UCN (Catholic University of North – CHILE) (P11) UNPSJB (National University of Patagonia San Juan Bosco – ARGENTINA) In the context of the ChemBioFight project – 1st April 2011 till 31st of March 2015 Core scientific knowledge was produced and exchanged in the field of Phytochemistry, Pharmacognosy, Natural products Chemistry, Biology, Parasitology, Pharmacology, Synthesis of Natural Products, Analytical Chemistry, Metabolomics etc Several training events (seminars, lectures, talks) during the secondments of the experienced researchers as well as ChemBioFight Workshops gave the opportunity to the involved researchers to be trained in different and novel research topics Several announcements and participations in scientific conferences and scientific publications in peer-reviewed journals resulted to dissemination of knowledge produced in the context of the project as well as awareness of scientific community and public about Marie Curie funding schemes. Achieved objectives Based on the implemented secondments, in silico models able to predict hit compounds against Chagas disease and Leishaniasis has been generated and validated using compounds libraries of the consortium. Several plants from European and South American flora have been collected, extracted and screened biologically. Promising plant extracts have been phytochemically analysed and numerous secondary metabolites have been identified. Meatabolic profiling approaches have been implemented in selected plant species aiming to the correlation of phytocemical content with the observed biological patterns. Finally, synthetic analogues of active natural scaffolds have been produced. • >100 plants from Europe and S. America were collected and extracted • >25 plant extracts were phytochemicaly investigated • >120 compounds were isolated and identified • >80 compounds were synthesised • >10 plant extracts were investigated using dereplication and metabolomics approaches • >65 extracts and 100 compounds were evaluated against Chagas disease • >110 extracts and 90 compounds were evaluated against Leishmaniasis Numerous secondments of experienced and early stage researchers were realised from EU to South America and vice versa. In specific, the first two years (2011-2013) 31 secondments took place while the second period (2013-2015) 50 secondments were performed. In total, 81 secondments were implemented. All of the knowledge and technical know-how necessary for modern science cannot be found in a single country. ChemBioFight offered a propitious opportunity for the development of profitable links between academic groups in Europe and in South America ChemBioFight brought closer different research organisations and universities and facilitated their future cooperation. ChemBioFight facilitated the innovation system in Europe encouraging the use of knowledge and the sharing of research results, through the recognition of experience in this field as well as through the exchange of best practices ChemBioFight assisted the mobility of European researchers to South America and vice versa ChemBioFight contributed to the career prospects of researchers at all stages of their career by adding skills to scientific expertise, notably regarding IPR and innovation, communication, networking and team working ChemBioFight attracted some of the most talented researchers worldwide and contribute to counter the brain drain of Europe’s and South America talented students and researchers ChemBioFight developed new networks of excellence in the field discovering new bioactive natural products for neglected diseases

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

The ChemBioFight project aims towards the exploration of natural resources to the discovery of bioactive therapeutic molecules against leishmania and Chagas disease. This will be accomplished through the establishment of an extended scientific network between European and South American research entities. Already assembled, highly diverse chemical libraries will be employed for the determination of active natural scaffolds leading to the focused collection of biomaterial (plants, marine organisms, fungi, endophytes) from local diversity hot-spots. Automated, high throughput and advanced techniques will be incorporated for the extraction process as well as the isolation and identification of natural products. Sophisticated approaches as metabolomics and chemical profiling will contribute to the discovery of novel active compounds and will be used to conduct dereplication procedures. Semi-synthetic derivatives of lead compounds will be also produced aiming to the optimization of favorable biological properties via medicinal chemistry aspects. In every step of the proposed work flow, the obtained samples (extracts, isolated compounds, synthetic derivatives) will be evaluated in vitro and/or in vivo for their antileishmanial and antitrypanosomal activity. Within the aforementioned context, an extensive net of secondements, both with educational and experimental attributes, will be established. Core scientific knowledge is expected to be produced and exchanged, with the prospect of creating partnerships with future scientific potential. All partners will participate in the dissemination procedure through teaching activities, workshops and international conferences, leading overall to mutual transfer of know-how. Finally, all procedures will be effectively monitored from a management team ensuring effectiveness and prompt objective achievement.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз